The size of the amlodipine besilate market will grow by USD 217.26 million; High blood pressure segment exhibits high growth

NEW YORK, November 22, 2022 /PRNewswire/ — The “Amlodipine Besilate Market By Application & Geography: Forecast & Analysis 2022-2026The report has been added to the Technavio offer. The report expects the market size to be projected by $217.26 million, accelerating to a CAGR of 3.6% over the forecast period. The report provides detailed analysis of the impact of the COVID-19 pandemic on the amlodipine besilate market under optimistic, likely and pessimistic forecast scenarios. Technavio offers up-to-date analysis of the current global market scenario and general market environment. Download a free sample PDF report

Technavio has announced its latest market research report titled Global Amlodipine Besylate Market 2022-2026.

Technavio has announced its latest market research report titled Global Amlodipine Besylate Market 2022-2026.

Amlodipine Besilate Market 2022-2026: Scope

Market trends such as increasing use of amlodipine besilate in various treatments are likely to emerge as one of the major market drivers. However, factors such as side effects on human health can threaten the growth of the market. To help companies improve their position in the market, the Technavio report provides a detailed analysis of around 25 vendors operating in the market.

The report also covers the following areas:

Amlodipine Besilate Market 2022-2026: Segmentation

High blood pressure is a common problem that can damage the brain, heart, blood vessels, kidneys, and other parts of the body. If left untreated, high blood pressure can lead to serious health problems, including heart attack, heart failure, stroke, kidney failure, and vision loss. A patient with high blood pressure should continue to take amlodipine even if they feel well. High blood pressure is often not noticed until it becomes a problem. It is generally suggested that a person may need to take blood pressure medication for the rest of their life. Amlodipine is used to prevent angina (chest pain), which can be a sign of a heart problem. It can help increase exercise capacity and decrease the frequency of angina attacks in patients with high blood pressure.

39% of market growth will come from North America during the forecast period. The market is growing in this region mainly due to the high incidence of hypertension in the US, which translates into increasing consumption of amlodipine besilate. The United States is the dominant country in the region and acts as the main income generator, followed by Canada. Large investments in the pharmaceutical business, the existence of pharmaceutical players in the region, a high prevalence rate of heart failure cases and the huge economic burden related to it are important factors supporting the growth of the regional market. Discover other potential segments and regions in the market. purchase report

Technavio’s library includes more than 17,000 reports covering more than 2,000 emerging technologies. Subscribe to our “Basic Plan” in just US$5,000 and get lifetime access to Technavio Insights

Amlodipine Besilate Market 2022-2026: Vendor Analysis

The market is fragmented and the degree of fragmentation will accelerate during the forecast period. Amsal Chem SA Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., CENTURY PHARMACEUTICALS Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., MOEHS IBERICA SL, Rakshit Drugs Pvt. Ltd., VPL Chemicals SA Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Pfizer Inc., Apotex Inc., Lupin Ltd., Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., Chartwell Pharmaceuticals LLC, Synthon International Holding BV, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd. and Orbion Pharmaceuticals Pvt. Ltd. are some of the major market participants.

The increasing incidence of hypertension will offer immense opportunities for growth. To take advantage of current opportunities, market vendors must strengthen their position in fast-growing segments while maintaining their positions in slow-growing segments. Get detailed information about the drivers, trends and challenges in the growth of the market. Download a free sample report

Amlodipine Besilate Market 2022-2026: Key Aspects

  • Market CAGR over the forecast period 2022-2026

  • Detailed information on the factors that will help the growth of the amlodipine besilate market during the next five years.

  • Estimation of the amlodipine besilate market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • The growth of the amlodipine besilate market

  • Analysis of the competitive landscape of the market and detailed information about the vendors.

  • Comprehensive details of factors that will challenge the growth of amlodipine besilate market vendors

Related reports:

  • the Acute Ischemic Stroke (AIS) Therapeutic Market The report is a comprehensive research document that provides in-depth qualitative and quantitative intelligence. Technavio analysts estimate a growth in the market share of USD 1,524.49 million from 2022 to 2027, at a CAGR of 5.72%. Innovative features and user interfaces are remarkably driving the growth of the acute ischemic stroke therapy market, although factors such as unmet needs for anticoagulant reversal agents may impede market growth.

  • the bronchiectasis drug market participation is expected to increase in $276.16 million from 2021 to 2026, and the market growth momentum will accelerate at a CAGR of 9.31%. The increasing prevalence of associated risk factors is a key factor driving the growth of the global market for bronchiectasis drugs. The lack of approved drugs for bronchiectasis is the main challenge for the growth of the global market for bronchiectasis drugs.

Scope of Amlodipine Besilate Market

Report Coverage

Details

Page number

120

base year

2021

forecast period

2022-2026

Growth momentum and CAGR

Accelerate at a CAGR of 3.6%

Market growth 2022-2026

$217.26 million

Market structure

Fragmented

YoY growth (%)

3.0

regional analysis

North America, Europe, Asia and Rest of the World (ROW)

Contribution to the real market

North America at 39%

Main consumer countries

United States, Canada, Germany, United Kingdom and China

competitive landscape

Leading companies, competitive strategies, scope of consumer engagement

Profiled companies

Amsal Chem SA Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., CENTURY PHARMACEUTICALS Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., MOEHS IBERICA SL, Rakshit Drugs Pvt. Ltd., VPL Chemicals SA Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Pfizer Inc., Apotex Inc., Lupin Ltd., Strides Pharma Science Ltd., Teva Pharmaceutical Industries Ltd., Chartwell Pharmaceuticals LLC, Synthon International Holding BV, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd. and Orbion Pharmaceuticals Pvt. Limited.

Market dynamics

Analysis of the main market, drivers and obstacles of market growth, analysis of fast and slow growing segments, impact of COVID-19 and future consumer dynamics, and analysis of the market condition for the forecast period.

scope of customization

If our report didn’t include the data you’re looking for, you can contact our analysts and get custom segments.

Table of Contents:

1. Executive Summary

2 Market overview

3 Market size

4 Five Forces Analysis

5 Market Segmentation by Application

6 Customer Landscape

7 Geographic Landscape

8 drivers, challenges and trends

9 Supplier Landscape

10 Vendor Analysis

11 Appendix

About us

Technavio is a world leading technology research and advisory company. His research and analysis focus on emerging market trends and provide actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With more than 500 dedicated analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies and spanning 50 countries. Its client base consists of companies of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, in-depth research, and actionable market insights to identify opportunities in existing markets and potentials and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
media and marketing executive
USA: +1 844 364 1100
United Kingdom: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Global Amlodipine Besilate Market 2022-2026

Global Amlodipine Besilate Market 2022-2026

cleavage

cleavage

See original content to download multimedia:https://www.prnewswire.com/news-releases/amlodipine-besylate-market-size-to-grow-by-usd-217-26-million-high-blood-pressure-segment-exhibits-high-growth- –technavio-301685139.html

SOURCE Technavio

Leave a Reply

Your email address will not be published.